Adipose MSCs Response to Breast Cancer Cell-derived Factors in Conditioned Media and Extracts

Overview

Journal Cell Tissue Bank

Specialties Anatomy & Histology
Cell Biology
General Surgery

Date 2024 Dec 29

PMID 39733372

Authors

Fatemeh Sadeghian

Faezeh Kazemi

Ali Pirsadeghi

Fatemeh Asadi

Mahnaz Tashakori

Aliakbar Yousefi-Ahmadipour

Affiliations

Soon will be listed here.

Abstract

Interactions between MSCs and cancer cells are complex and multifaceted and have been shown to exhibit both pro-tumor and antitumor effects. This study investigated the effects of conditioned medium (CM) and cell extract (CE) from two different ERα statuses, MCF-7 and MDA-MB-231 breast cancer cell lines, on adipose-derived mesenchymal stem cells (ASCs). Findings showed that CM and CE increased cellular metabolic activity and viability of ASCs, upregulated angiogenic factors VEGF and HIF-1α, and cytokine TGF-β expression levels. However, CM and CE treatment did not significantly affect the clonogenicity of ASCs. In addition, apoptosis-related genes caspase-3 and 9 showed differential expression patterns among the treatment groups. The findings suggest that breast cancer cell-derived factors can modulate the behavior of ASCs, highlighting their potential as a therapeutic tool in breast cancer treatment and tissue regeneration. However, it is essential to consider the potential risks associated with CM and CE treatment on ASCs, as well as the potential recruitment of ASCs by cancer tumors and the risks associated with this recruitment. Further research is needed to elucidate these potential risks and benefits.

References

Ahn S . The Role of MSCs in the Tumor Microenvironment and Tumor Progression. Anticancer Res. 2020; 40(6):3039-3047. DOI: 10.21873/anticanres.14284. View

Ahn J, Coh Y, Lee H, Shin I, Kang S, Youn H . Human adipose tissue-derived mesenchymal stem cells inhibit melanoma growth in vitro and in vivo. Anticancer Res. 2015; 35(1):159-68. View

Crusz S, Balkwill F . Inflammation and cancer: advances and new agents. Nat Rev Clin Oncol. 2015; 12(10):584-96. DOI: 10.1038/nrclinonc.2015.105. View

Dorronsoro A, Lang V, Ferrin I, Fernandez-Rueda J, Zabaleta L, Perez-Ruiz E . Intracellular role of IL-6 in mesenchymal stromal cell immunosuppression and proliferation. Sci Rep. 2020; 10(1):21853. PMC: 7736882. DOI: 10.1038/s41598-020-78864-4. View

Harrell C, Volarevic A, Djonov V, Jovicic N, Volarevic V . Mesenchymal Stem Cell: A Friend or Foe in Anti-Tumor Immunity. Int J Mol Sci. 2021; 22(22). PMC: 8622564. DOI: 10.3390/ijms222212429. View

Hass R . Role of MSC in the Tumor Microenvironment. Cancers (Basel). 2020; 12(8). PMC: 7464647. DOI: 10.3390/cancers12082107. View

Hill B, Pelagalli A, Passaro N, Zannetti A . Tumor-educated mesenchymal stem cells promote pro-metastatic phenotype. Oncotarget. 2017; 8(42):73296-73311. PMC: 5641213. DOI: 10.18632/oncotarget.20265. View

Hoang D, Pham P, Bach T, Ngo A, Nguyen Q, Phan T . Stem cell-based therapy for human diseases. Signal Transduct Target Ther. 2022; 7(1):272. PMC: 9357075. DOI: 10.1038/s41392-022-01134-4. View

Neophytou C, Panagi M, Stylianopoulos T, Papageorgis P . The Role of Tumor Microenvironment in Cancer Metastasis: Molecular Mechanisms and Therapeutic Opportunities. Cancers (Basel). 2021; 13(9). PMC: 8122975. DOI: 10.3390/cancers13092053. View

10.

Nooshabadi V, Mardpour S, Yousefi-Ahmadipour A, Allahverdi A, Izadpanah M, Daneshimehr F . The extracellular vesicles-derived from mesenchymal stromal cells: A new therapeutic option in regenerative medicine. J Cell Biochem. 2018; 119(10):8048-8073. DOI: 10.1002/jcb.26726. View

11.

Rakha E, Tse G, Quinn C . An update on the pathological classification of breast cancer. Histopathology. 2022; 82(1):5-16. PMC: 10108289. DOI: 10.1111/his.14786. View

12.

Robinson A, Sakkal S, Park A, Jovanovska V, Payne N, Carbone S . Mesenchymal stem cells and conditioned medium avert enteric neuropathy and colon dysfunction in guinea pig TNBS-induced colitis. Am J Physiol Gastrointest Liver Physiol. 2014; 307(11):G1115-29. DOI: 10.1152/ajpgi.00174.2014. View

13.

Sahai E, Astsaturov I, Cukierman E, DeNardo D, Egeblad M, Evans R . A framework for advancing our understanding of cancer-associated fibroblasts. Nat Rev Cancer. 2020; 20(3):174-186. PMC: 7046529. DOI: 10.1038/s41568-019-0238-1. View

14.

Sarsenova M, Kim Y, Raziyeva K, Kazybay B, Ogay V, Saparov A . Recent advances to enhance the immunomodulatory potential of mesenchymal stem cells. Front Immunol. 2022; 13:1010399. PMC: 9537745. DOI: 10.3389/fimmu.2022.1010399. View

15.

Song J, Kang H, Hong J, Kim C, Shim J, Lee C . Umbilical cord-derived mesenchymal stem cell extracts reduce colitis in mice by re-polarizing intestinal macrophages. Sci Rep. 2017; 7(1):9412. PMC: 5573412. DOI: 10.1038/s41598-017-09827-5. View

16.

Tashakori M, Asadi F, Khorram F, Manshoori A, Hosseini-Chegeni A, Moghadam F . Effects of MRI on stemness properties of Wharton's jelly-derived mesenchymal stem cells. Cell Tissue Bank. 2022; 24(3):523-533. DOI: 10.1007/s10561-022-10052-2. View

17.

Wang K, Ding D . Role of cancer-associated mesenchymal stem cells in the tumor microenvironment: A review. Tzu Chi Med J. 2023; 35(1):24-30. PMC: 9972927. DOI: 10.4103/tcmj.tcmj_138_22. View

18.

Yousefi-Ahmadipour A, Rashidian A, Mirzaei M, Farsinejad A, PourMohammadi-Nejad F, Ghazi-Khansari M . Combination therapy of mesenchymal stromal cells and sulfasalazine attenuates trinitrobenzene sulfonic acid induced colitis in the rat: The S1P pathway. J Cell Physiol. 2018; 234(7):11078-11091. DOI: 10.1002/jcp.27944. View

19.

Zhang L, Xiang J, Zhang F, Liu L, Hu C . MSCs can be a double-edged sword in tumorigenesis. Front Oncol. 2022; 12:1047907. PMC: 9685321. DOI: 10.3389/fonc.2022.1047907. View

20.

Zhao Q, Gregory C, Lee R, Reger R, Qin L, Hai B . MSCs derived from iPSCs with a modified protocol are tumor-tropic but have much less potential to promote tumors than bone marrow MSCs. Proc Natl Acad Sci U S A. 2014; 112(2):530-5. PMC: 4299223. DOI: 10.1073/pnas.1423008112. View